Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 291,998 | 273,114 | 261,765 | 257,063 | 255,323 |
| Cost of Goods | 49,375 | 45,713 | 47,135 | 43,902 | 42,654 |
| Gross Profit | 242,623 | 227,401 | 214,630 | 213,161 | 212,669 |
| Operating Expenses | 199,869 | 192,222 | 183,408 | 181,695 | 180,436 |
| Operating Income | 43,129 | 35,892 | 31,357 | 32,368 | 32,887 |
| Interest Expense | 10 | 15 | 10 | 11 | 10 |
| Other Income | 872 | 519 | 700 | 471 | 492 |
| Pre-tax Income | 43,991 | 36,396 | 32,047 | 32,828 | 33,369 |
| Income Tax | 15,045 | 42,247 | 8,278 | 9,569 | 12,011 |
| Net Income Continuous | 28,946 | -5,851 | 23,769 | 23,259 | 21,358 |
| Net Income | $28,946 | $-5,851 | $23,769 | $23,259 | $21,358 |
| EPS Basic Total Ops | 1.20 | -0.23 | 0.98 | 0.95 | 0.87 |
| EPS Basic Continuous Ops | 1.20 | -0.23 | 0.98 | 0.95 | 0.87 |
| EPS Diluted Total Ops | 1.19 | -0.23 | 0.97 | 0.93 | 0.86 |
| EPS Diluted Continuous Ops | 1.19 | -0.22 | 0.97 | 0.93 | 0.86 |
| EBITDA(a) | $47,660 | $40,205 | $35,488 | $36,568 | $36,353 |